Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyAmyloidosisTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
A MyAmyloidosisTeam Member asked a question 💭
June 7
 · 
Be the first to react
MyAmyloidosisTeam

Cardiac troponin I (cTnI) is a protein that shows up in the blood when heart muscle cells are damaged. It's used in an alternative cardiac staging system alongside brain natriuretic peptide (BNP), typically when NT-proBNP testing isn't available.

The normal cutoff for cTnI is less than 0.1 nanograms per milliliter. Here's Show Full Answer

Cardiac troponin I (cTnI) is a protein that shows up in the blood when heart muscle cells are damaged. It's used in an alternative cardiac staging system alongside brain natriuretic peptide (BNP), typically when NT-proBNP testing isn't available.

The normal cutoff for cTnI is less than 0.1 nanograms per milliliter. Here's how the staging breaks down based on cTnI and BNP levels:

- Stage 1 — Both BNP and cTnI are within normal range
- Stage 2 — Either BNP or cTnI is elevated
- Stage 3 — Both BNP and cTnI are elevated
- Stage 3B — BNP is very high (700 picograms per milliliter or more) and cTnI is also elevated

Higher stages generally indicate more serious heart involvement and are associated with a shorter life expectancy. Stage 3B in particular tends to have a more serious outlook.

It's always worth discussing your specific biomarker results with your care team, as they can give the most accurate picture of what the numbers mean for your individual situation.

June 7

Related Questions

View All
A MyAmyloidosisTeam Member asked a question 💭